Show Notes
In this episode, we’re joined by experts from Belgium, Luxembourg and the Netherlands, three nations that sit in the heart of the EU and take a collaborative approach to pharmaceuticals and healthcare.
We explore what challenges they are facing when new and innovative medicines are on the way to being authorised, what solutions are being pursued to ensure these treatments reach patients, and what this could mean for other countries in Europe.
This recording was organised and funded by Johnson & Johnson June 2024 CP-460080 Hosted on Acast. See acast.com/privacy for more information.
More from Transforming Health
In this episode, we explore why health should be seen as an investment, that delivers positive returns for individuals, economies and society as a whole.
This episode focuses on precision medicine in cancer – why it’s considered so revolutionary, and how we can work together to make it more accessible to every patient.
In this episode, our experts shine a light on the benefits of endoscopy in the long-term management of inflammatory bowel disease (IBD).
In this episode, we talk about the importance of shared decision-making in helping patients achieve a “life of possibility”, especially in complex illnesses like multiple myeloma.
In the final episode of Season 2, we look at the future of healthcare in Central Europe and the Baltics, a diverse region that covers almost one third of EU countries.